KUALA LUMPUR, Nov 21 (Bernama) -- The International Center for Genetic Disease (iCGD) at Brigham and Women’s Hospital and Harvard Medical School, launched a six-month nationwide programme to train 100 physicians across the United Arab Emirates (UAE) in clinical genomic medicine and genetic counselling, to help further genomic medicine’s global promise.
According to a statement, this training programme is implemented in collaboration with the Department of Health – Abu Dhabi and Khalifa University of Science and Technology.
The comprehensive partnership between iCGD, Mass General Brigham, and the Department of Health – Abu Dhabi will help advance life sciences and health care outcomes globally while leveraging the advanced genomics capabilities of the Emirate.
Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all' approach to one utilising an individual’s genetic profile, informing their personalised care pathway from prevention and diagnosis, to treatment of diseases and the development of novel and more effective drugs.
With an emphasis on screening, diagnosis, and treatment of a wide spectrum of genetic conditions, clinicians will become deft with the necessary knowledge and skills to address genetic and genomic challenges in a clinical setting.
Additionally, the programme ensures the successful execution of the Emirati Genome Program, bringing precision medicine to the forefront of public health policy formulation and implementation across the UAE.
Delivered by globally recognised Harvard-affiliated experts within the Mass General Brigham system and elsewhere, the programme will enhance the knowledge and expertise of Emirati physicians, who will then be able to further incorporate the latest innovations in genomic medicine and genetic counselling into the clinical care of patients.
The iCGD designed the programme to specifically address the public health needs of the UAE.
By integrating clinical data and genetic information, healthcare providers can improve population screening, diagnosis, prognosis, risk management, and in some cases, offer new and innovative targeted therapy for conditions including cardiovascular diseases, lipid disorders, diabetes, among many other clinically complex morbidities.
-- BERNAMA
No comments:
Post a Comment